Anticoagulation in patients with atrial fibrillation and liver cirrhosis

Atrial fibrillation (AF) is an increasingly recognized comorbidity in patients with liver cirrhosis, mainly associated with nonalcoholic fatty liver disease and alcohol-associated liver disease, affecting the quality of life and prognosis. On the other hand, cirrhosis is associated with an elevated...

Descripción completa

Detalles Bibliográficos
Autores principales: Karapedi, Eleni, Papadopoulos, Nikolaos, Trifylli, Eleni-Myrto, Koustas, Evangelos, Deutsch, Melanie, Aloizos, Georgios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648530/
https://www.ncbi.nlm.nih.gov/pubmed/36406965
http://dx.doi.org/10.20524/aog.2022.0745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648530/
https://www.ncbi.nlm.nih.gov/pubmed/36406965
http://dx.doi.org/10.20524/aog.2022.0745

Ejemplares similares